Stewart Tepper, MD, Professor of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH, discusses the results of the CONQUER study (NCT03559257), which evaluated the safety and efficacy of galcanezumab in patients with treatment-resistant episodic or chronic migraine. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).